Related Experiment Videos
Baroreflex and chemoreflex dysfunction in streptozotocin-diabetic rats
P Dall'Ago1, T G Fernandes, U F Machado
1Departamento de Fisiologia, Universidade Federal do Rio do Sul, RS, Brasil.
This study investigated how diabetes affects the body's ability to regulate heart rate and blood pressure through reflex mechanisms. Researchers compared diabetic and control rats to assess baroreflex and chemoreflex sensitivity. They found that both types of reflexes were significantly impaired in diabetic rats. The study measured heart rate and blood pressure changes using pharmacological agents and a data acquisition system. The findings suggest that diabetes leads to autonomic dysfunction, which may contribute to cardiovascular instability. The results confirm prior observations and provide a clearer understanding of how diabetes affects reflex control. The study does not propose new mechanisms but supports existing theories about diabetic complications.
Area of Science:
- Cardiovascular physiology
- Diabetic complications research
- Autonomic nervous system function
Background:
Prior research has shown that diabetes can affect how the body regulates heart rate and blood pressure. Established knowledge includes the role of the autonomic nervous system in controlling these functions. However, uncertainty remains about how diabetes specifically alters reflex responses. No prior work had resolved whether changes in heart rate and blood pressure in diabetic animals are due to peripheral neuropathy or direct autonomic dysfunction. This gap motivated the present investigation into cardiovascular reflexes in diabetic rats. The study builds on prior findings that streptozotocin-induced diabetes alters autonomic control. It also addresses the unresolved question of how chemoreflex and baroreflex responses are affected. The research fills a need to understand the mechanisms behind cardiovascular instability in diabetes. By focusing on reflex sensitivity, it provides a new perspective on diabetic complications.
Purpose Of The Study:
The aim of this study was to evaluate how diabetes affects the body's ability to regulate heart rate and blood pressure through reflex mechanisms. The researchers focused on baroreflex and chemoreflex sensitivity in diabetic rats. They sought to determine if these reflexes are impaired in streptozotocin-induced diabetes. The motivation was to clarify whether cardiovascular instability in diabetes is due to autonomic dysfunction. The study also aimed to quantify the extent of reflex impairment in diabetic rats. By comparing diabetic and control groups, the researchers tested the hypothesis that diabetes alters reflex responses. The study design allowed for precise measurement of heart rate and blood pressure changes. The findings could help explain the physiological basis of cardiovascular complications in diabetes.
Main Methods:
The study used male Wistar rats divided into control and diabetic groups. Diabetes was induced with streptozotocin (50 mg/kg, i.v.) and monitored for 15 days. Intra-arterial blood pressure was measured using a data acquisition system (CODAS, 1 kHz). Baroreflex sensitivity was assessed by measuring heart rate changes in response to phenylephrine and sodium nitroprusside. Chemoreflex sensitivity was evaluated using potassium cyanide to activate chemoreceptors. Heart rate and arterial pressure data were collected for both groups. The study compared resting heart rate and blood pressure between control and diabetic rats. Reflex responses were quantified using standardized doses of pharmacological agents. The experimental approach allowed for precise quantification of reflex impairments.
Main Results:
Diabetic rats showed significantly higher blood glucose levels (447 +/- 49 mg/dl) compared to controls (126 +/- 3 mg/dl). Resting heart rate was reduced in diabetic rats (296 +/- 11 bpm) compared to controls (355 +/- 16 bpm). Arterial pressure was also lower in diabetic rats (99 +/- 3 mmHg) compared to controls (118 +/- 2 mmHg). Baroreflex sensitivity was impaired in diabetic rats, with reduced bradycardic response (-16.8 +/- 0.1 vs -12.5 +/- 0.1 bpm/mmHg). Tachycardic response to depressor agents was also diminished (-3.68 +/- 0.5 vs -1.75 +/- 0.3 bpm/mmHg). Chemoreflex-induced bradycardia was attenuated in diabetic rats (control: -208 +/- 17 vs diabetic: -140 +/- 13 bpm). Pressor responses to chemoreflex activation were also reduced (control: 59 +/- 5 vs diabetic: 42 +/- 5 mmHg). These findings indicate significant impairment of both baroreflex and chemoreflex sensitivity in diabetic rats.
Conclusions:
The authors concluded that both baroreflex and chemoreflex responses are impaired in streptozotocin-induced diabetic rats. The study found that heart rate and blood pressure regulation are significantly altered in diabetic animals. The observed changes suggest a dysfunction in autonomic control of cardiovascular responses. The findings support the hypothesis that diabetes affects reflex sensitivity. The study did not propose new mechanisms but confirmed prior observations in a controlled setting. The results align with the idea that autonomic dysfunction contributes to cardiovascular instability in diabetes. The authors did not suggest future directions or new therapeutic approaches. The conclusions are based on direct comparisons between diabetic and control groups.
Frequently Asked Questions
The study found that both baroreflex and chemoreflex sensitivity are significantly impaired in streptozotocin-induced diabetic rats.
Baroreflex sensitivity was measured by assessing heart rate changes in response to phenylephrine and sodium nitroprusside injections.
Potassium cyanide was used to activate chemoreceptors and evaluate bradycardic and pressor responses in diabetic and control rats.
The CODAS system sampled intra-arterial blood pressure at 1 kHz to accurately measure cardiovascular responses.
Diabetic rats had a resting heart rate of 296 +/- 11 bpm compared to 355 +/- 16 bpm in controls.
The authors suggest that the observed reflex impairments may be secondary to autonomic dysfunction in diabetic rats.